Evidence map›Paper›PMID 24436049›Full record

ArticleCancer discovery2014

Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.

Sally M Dewhurst, Nicholas McGranahan, Rebecca A Burrell, Andrew J Rowan, Eva Grönroos, David Endesfelder, Tejal Joshi, Dmitri Mouradov, Peter Gibbs, Robyn L Ward and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer discovery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 284 papers.

0numbers the graph read from it
0cells of the map it votes in
284citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

284 citing papers in PubMed, 462 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Growth under pressure: The pros and cons of polyploidy induced by stress.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Review
  11. Oxidative stress and serum deprivation influence the evolution of newly formed tetraploid cells during tumorigenesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

224 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 6 countries.

Sally M Dewhurst *Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Nicholas McGranahan *Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Rebecca A BurrellCancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Andrew J RowanCancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Eva GrönroosCancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
David EndesfelderUniversity of Applied Sciences Koblenz, RheinAhrCampus, Department of Mathematics and Technology, Joseph-Rovan-Allee 2, 53424 Remagen, Germany.
Tejal JoshiTechnical University of Denmark (DTU), Anker Engelunds Vej 1, 2800 Lyngby, Denmark.
Dmitri MouradovSystems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute, Parkville, VIC, Australia.
Peter GibbsSystems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute, Parkville, VIC, Australia.
Robyn L WardLowy Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
Nicholas J HawkinsSchool of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
Zoltan SzallasiTechnical University of Denmark (DTU), Anker Engelunds Vej 1, 2800 Lyngby, Denmark.
Oliver M SieberSystems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute, Parkville, VIC, Australia.
Charles SwantonCancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
CRUK Lung Cancer Centre of Excellence · GBUniversity College London · GBUNSW Sydney · AUWalter and Eliza Hall Institute of Medical Research · AUCancer Research UK · GBHarvard University · USKoblenz University of Applied Sciences · DEPersonalis (United States) · USPrince of Wales Hospital · CNTechnical University of Denmark · DK

Funding

Cancer Research UK A11590Cancer Research UK A17786Cancer Research UK A19310European Research Council 617844Medical Research Council G0701935Medical Research Council G0701935/2
6 · The paper itself

Abstract

unlabelledThe contribution of whole-genome doubling to chromosomal instability (CIN) and tumor evolution is unclear. We use long-term culture of isogenic tetraploid cells from a stable diploid colon cancer progenitor to investigate how a genome-doubling event affects genome stability over time. Rare cells that survive genome doubling demonstrate increased tolerance to chromosome aberrations. Tetraploid cells do not exhibit increased frequencies of structural or numerical CIN per chromosome. However, the tolerant phenotype in tetraploid cells, coupled with a doubling of chromosome aberrations per cell, allows chromosome abnormalities to evolve specifically in tetraploids, recapitulating chromosomal changes in genomically complex colorectal tumors. Finally, a genome-doubling event is independently predictive of poor relapse-free survival in early-stage disease in two independent cohorts in multivariate analyses [discovery data: hazard ratio (HR), 4.70, 95% confidence interval (CI), 1.04-21.37; validation data: HR, 1.59, 95% CI, 1.05-2.42]. These data highlight an important role for the tolerance of genome doubling in driving cancer genome evolution. SIGNIFICANCE: Our work sheds light on the importance of whole-genome–doubling events in colorectal cancer evolution. We show that tetraploid cells undergo rapid genomic changes and recapitulate the genetic alterations seen in chromosomally unstable tumors. Furthermore, we demonstrate that a genome-doubling event is prognostic of poor relapse-free survival in this disease type.

Indexed as

Chromosomal InstabilityCell Line, TumorColorectal NeoplasmsDNA Copy Number VariationsHumansNeoplasmsPhenotypePloidiesPolyploidyPrognosis

Identifiers

PMID24436049
PMCPMC4293454
OpenAlexW2137220794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.